ZEO:NASDAQZeo Energy Corporation Analysis
Data as of 2026-05-12 - not real-time
$0.92
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Zeo Energy Corp. (ZEO) trades at $0.92, comfortably above its 20‑day (≈$0.87) and 50‑day (≈$0.83) simple moving averages but still below the 200‑day SMA (≈$1.28), indicating short‑term momentum in a longer‑term downtrend. The RSI sits at 55, suggesting neutral price pressure, while a bullish MACD crossover (+0.003) provides a modest technical upside bias. The stock is perched between a clear support zone at $0.56 and resistance near $1.12, with recent volume trending lower, hinting at waning participation. Volatility is extreme, with a 30‑day swing of roughly 119% and a computed beta near 1.9, exposing the equity to amplified market moves. Fundamentally, the company is distressed: revenue has slipped 0.4%, operating margin is –22.7%, and both operating and free cash flow are deeply negative. The balance sheet shows a debt‑to‑equity ratio of nearly 3× and a negative book value per share (‑$0.055), resulting in a nonsensical price‑to‑book of –16.8. Despite a modest price‑to‑sales of 1.6, the lack of earnings (PE = 0) and zero dividend underscore cash‑flow strain. The “Extreme Greed” market sentiment (Fear & Greed Index 88) may be inflating price expectations despite these weaknesses. Overall, the technical setup offers a thin upside window, but the underlying financial health and high volatility present significant downside risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above short‑term SMAs but below long‑term SMA
- Bullish MACD but decreasing volume
- Support level provides downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Negative margins and cash flow limit upside
- High debt‑to‑equity ratio raises solvency concerns
- Sector volatility and regulatory exposure
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- Sustained operating losses and negative free cash flow
- Negative book value and unrealistic price‑to‑book ratio
- Elevated beta and historical max drawdown of >84%
Key Metrics & Analysis
Financial Health
Revenue Growth-0.40%
Profit Margin-20.20%
ROE-43.43%
ROA-21.77%
Debt/Equity2.99
P/B Ratio-16.8
Op. Cash Flow$-8691421
Free Cash Flow$-6161290
Industry P/E39.0
Technical Analysis
TrendNeutral
RSI54.8
Support$0.56
Resistance$1.12
MA 20$0.87
MA 50$0.83
MA 200$1.28
MACDBullish
VolumeDecreasing
Fear & Greed Index87.98
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.89
Volatility118.95%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.